抗CCP抗体在类风湿性关节炎诊断中的应用进展
Progress of anti-CCP antibody in the application of diagnosis of rheumatoid arthritis
  
DOI:10.3969/j.issn.1006.7108.2014.11.025
中文关键词:  抗CCP抗体  类风湿性关节炎  类风湿因子
英文关键词:Anti-CCP  Rheumatoid arthritis  Rheumatoid factors
基金项目:国家自然科学基金面上项目赞助课题(81072546)
作者单位
梁海1,2 吴久鸿2* 向卓2 张学辉2 1.安徽医科大学研究生学院合肥230032 2.解放军第306医院药学部北京100101 
摘要点击次数: 1561
全文下载次数: 1301
中文摘要:
      目前类风湿关节炎的诊断检查有炎性标志物(包括血沉和C反应蛋白)检测,免疫复合物和补体检测,关节滑液检测以及自身抗体检测。这些指标经常伴随类风湿关节炎的活动而改变,早期诊断主要依靠的是自身抗体检测。抗环瓜氨酸肽 (cyclic citrullinated peptide,CCP)抗体是一种抗角蛋白抗体,在类风湿性关节炎的敏感度和特异度较类风湿因子高。发病一年内,类风湿性关节炎患者大部分血清中可检测到抗CCP抗体的存在,同时抗CCP抗体阳性也可以用来预测严重破坏的类风湿性关节炎。因此,抗CCP抗体对于类风湿性关节炎的早期诊断及预后评估是极有帮助的。本文综述了近年来抗CCP抗体对于诊断类风湿关节炎的应用进展。
英文摘要:
      Currently the markers for the diagnosis of rheumatoid arthritis include inflammatory makers ( including blood sedimentation and C-reactive protein),immune complexe and complement detection,detection of joint synovial fluid,and detection of autoantibodies. These indicators change with the activity of arthritis. Early diagnosis relies mainly on detection of autoantibodies. Anti-cyclic citrullinated peptide antibody (anti-CCP) is a kind of anti-keratin antibody,having higher sensitivity and specificity than the rheumatoid factor in diagnosis of rheumatoid arthritis. During the first year of rheumatoid arthritis,the existence of anti-CCP can be detected in the serum of most of these people. Positive anti-CCP can also be used to predict serious damage. Therefore,anti-CCP is extremely helpful in early diagnosis and prognosis assessment of rheumatoid arthritis. In this paper,the recent application of anti- CCP in the diagnosis of rheumatoid arthritis is reviewed.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=36358E19F9C507AE0BB60FA6A86D32039409653367E4F17ACEAD926C888EEE6FA76CF6486264A7C07101CF9CC8AB98B687DA472BED53C313E6BB13EA4E788970BBA1E4D30FD7041E439CFB0661D554E023DB2155AE44F823&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=9EAD63ADE6B277ED&aid=464AF871BCDA6A0E9520C8531FA31DD6&vid=&iid=708DD6B15D2464E8&sid=A9251EF312FA9D67&eid=92C3E863545428B5&fileno=201411025&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="9EAD63ADE6B277ED"; var my_aid="464AF871BCDA6A0E9520C8531FA31DD6";